???global.info.a_carregar???
Joaquim José Coutinho Ferreira. Concluiu o(a) Doutoramento em Medicina (Neurologia) em 2009 pelo(a) Universidade de Lisboa Faculdade de Medicina e Licenciatura em Medicina em 1992 pelo(a) Universidade de Lisboa Faculdade de Medicina. Recebeu 3 prémio(s) e/ou homenagens. No seu currículo Ciência Vitae os termos mais frequentes na contextualização da produção científica, tecnológica e artístico-cultural são: Neurologia; Ensaios clínicos; Investigação médica - Relatórios de estágio; Biomedicina farmacêutica; Clinical research; Clinical trials; Observational studies; Clinical trials coordination; Clinical data management; Medical writing; Pharmacovigilance; Neurology; Pharmaceutical biomedicine; Farmacovigilância; regulatory affairs; clinical trials; pharmacovigilance; clinical research; medical writing; Biomedicina; Clinical Investigation Centre; Laboratory of Clinical Pharmacology and Therapeutics; Pharmacovigilance Unit of Lisbon and Tejo Valley; Clinical Pharmacology Unit; CT coordination; Systematic reviews; CT; OS; Farmacologia clínica; Doença de Parkinson; Placebo; Nocebo; Domínio/Área Científica::Ciências Médicas; Ensaios clínicos - Monitorização; Mestrado; Estágio curricular; Investigação clínica; Coordenador de estudos; Gestão de dados; Master’s degree; Pharmaceutical medicine; Curricular internship; Clinical reasearch; Study coordinator; Data management; This report describes in detail the tasks and activities developed in the context of a curricular internship during the ; Clinical trial coordination; meta-analyzes; observational studies; Indústria farmacêutica; Testes clínicos; Monitorização; Investigação médica; Coordenação; Centro de investigação clínica; Revisões sistemáticas; Medicina farmacêutica; Master’s Degree in Pharmaceutical Medicine; Clinical Trials; Observational Studies; Clinical Research; Clinical Research Unit; Coordination of Clinical Trials; Monitoring; Clinical Research Centre; Coordination of Clinical Studies; Medical Writing; Análise de dados; Meta-analyzes; Farmacologia; Pharmaceutical Biomedicine; Clinical Pharmacology; Clinical Trials Coordination; .
Ler resumo completo ↓
Identificação

Identificação pessoal

Nome completo
Joaquim José Coutinho Ferreira

Nomes de citação

  • Ferreira, JJ
  • Ferreira, Joaquim
  • Ferreira, J

Identificadores de autor

Ciência ID
7D15-5CD6-6159
ORCID iD
0000-0003-3950-5113

Idiomas

Idioma Conversação Leitura Escrita Compreensão Peer-review
Inglês Utilizador proficiente (C1) Utilizador proficiente (C1) Utilizador proficiente (C1) Utilizador proficiente (C1)
Espanhol; Castelhano Utilizador independente (B1) Utilizador proficiente (C1) Utilizador independente (B1) Utilizador independente (B1)
Francês Utilizador proficiente (C1) Utilizador proficiente (C1) Utilizador independente (B1) Utilizador proficiente (C1)
Português Utilizador proficiente (C1) Utilizador proficiente (C1) Utilizador proficiente (C1) Utilizador proficiente (C1)
Formação
Grau Classificação
2015
Concluído
 Consultor de Neurologia da Carreira Médica Hospitalar (Título de especialista)
Ordem dos Médicos, Portugal
 Ordem dos Médicos
2009
Concluído
 Doutoramento em Medicina (Doutoramento)
Especialização em Neurologia
Universidade de Lisboa Faculdade de Medicina, Portugal
"Anti-Parkinsonian drugs and sleep disorders in Parkinson’s Disease" (TESE/DISSERTAÇÃO)
2008
Concluído
 Especialista em Farmacologia Clínica (Título de especialista)
Ordem dos Médicos, Portugal
2001
Concluído
 Especialista em Neurologia (Título de especialista)
Hospital de Santa Maria, Portugal
 19.7
1986 - 1992
Concluído
 Medicina (Licenciatura)
Universidade de Lisboa Faculdade de Medicina, Portugal
"MD" (TESE/DISSERTAÇÃO)
 17
Percurso profissional

Docência no Ensino Superior

Categoria Profissional
Instituição de acolhimento 		Empregador
2017 - 2018 Professor Associado (Docente Universitário) Universidade de Lisboa, Portugal
2016 - 2017 Professor Associado Convidado (Docente Universitário) Universidade de Lisboa, Portugal
2013 - 2016 Professor Associado (Docente Universitário) Universidade de Lisboa Faculdade de Medicina, Portugal

Cargos e Funções

Categoria Profissional
Instituição de acolhimento 		Empregador
2017 - 2020 Presidente do Conselho Pedagógico Universidade de Lisboa Faculdade de Medicina, Portugal
Universidade de Lisboa Faculdade de Medicina, Portugal
2015 - 2016 Coordenação ou direção de centro de investigação, departamento ou equivalente Universidade de Lisboa Faculdade de Medicina, Portugal
Projetos

Projeto

Designação Financiadores
2019/11/01 - 2024/10/31 IDEA-FAST
853981-2
Investigador
Instituto de Medicina Molecular, Portugal
 EU Framework Programme for Research and Innovation Science with and for Society
Em curso
2015 - 2020 Fair-ParK-II: Conservative iron chelation as a disease-modifying strategy in Parkinson’s disease: a multicentric, parallel-group, placebo-controlled, randomized clinical trial of deferiprone.
633190
Investigador
Instituto de Medicina Molecular, Portugal
 EU Framework Programme for Research and Innovation Science with and for Society
Em curso
2014 - 2018 FRALUSOPARK Dysarthria in Parkinson’s disease: Lusophony vs. Francophony comparison
FCT-ANR/NEU-SCC/0005/2013
Investigador
Instituto de Medicina Molecular, Portugal
 Agence nationale de la recherche
Concluído
2014 - 2017 COURAGE-PD COmprehensive Unbiased Risk Factor Assessment for Genetics and Environment in Parkinson’s Disease
JPND-RF/0001/2012
Investigador
Instituto de Medicina Molecular, Portugal
 EU Joint Programme Neurodegenerative Disease Research
Concluído
2014 - 2017 CLaSP: Care for Late Stage Parkinsonism
JPND-HC/0002/2012
Investigador
Instituto de Medicina Molecular, Portugal
 EU Joint Programme Neurodegenerative Disease Research
Concluído
2012 - 2015 SENSE-PARK: Sporting and Empowering Parkinson patients in their home environment using a Novel Sensory information system that monitors daily life-relevant parameters of Parkinson disease and their change
FP7-INFSO-ICT-288557
Investigador
Instituto de Medicina Molecular, Portugal
Concluído
Produções

Publicações

Artigo em revista
  1. M. Alves; D. Caldeira; J. M. Ferro; J. J. Ferreira. "Reply to letter: Does Parkinson’s disease increase the risk of cardiovascular events? A systematic review and meta-analysis". European Journal of Neurology 27 2 (2020): https://doi.org/10.1111/ene.14125.
    10.1111/ene.14125
  2. Rita Moiron Simões; Ana Castro Caldas; Joaquim J Ferreira. "Inhaled levodopa for intermittent treatment of OFF episodes in patients with Parkinson’s disease". Expert Review of Clinical Pharmacology (2020): https://doi.org/10.1080/17512433.2020.1724535.
    10.1080/17512433.2020.1724535
  3. Raquel Bouça-Machado; Gonçalo S. Duarte; Maria Patriarca; Ana Castro Caldas; Joana Alarcão; Ricardo M. Fernandes; Tiago A. Mestre; Ricardo Matias; Joaquim J. Ferreira. "Measurement Instruments to Assess Functional Mobility in Parkinson's Disease: A Systematic Review". Movement Disorders Clinical Practice (2020): https://doi.org/10.1002/mdc3.12874.
    10.1002/mdc3.12874
  4. Cláudia M. Silva; André M. Travessa; Raquel Bouça-Machado; Daniel Caldeira; Joaquim J. Ferreira. "Reporting and methodological quality of clinical trials on exercise therapy for Parkinson's disease". Parkinsonism & Related Disorders 69 (2019): 150-156. https://doi.org/10.1016/j.parkreldis.2019.11.011.
    10.1016/j.parkreldis.2019.11.011
  5. Daniel Caldeira; Bárbara Rodrigues; Cláudio David; João Costa; Fausto J. Pinto; Joaquim J. Ferreira. "The association of influenza infection and vaccine with myocardial infarction: systematic review and meta-analysis of self-controlled case series". Expert Review of Vaccines (2019): 1-7. https://doi.org/10.1080/14760584.2019.1690459.
    10.1080/14760584.2019.1690459
  6. Margherita Fabbri; Miguel Coelho; Daisy Abreu; Joaquim J. Ferreira. "Levodopa response in later stages of Parkinson's disease: A case-control study". Parkinsonism & Related Disorders (2019): https://doi.org/10.1016/j.parkreldis.2019.10.027.
    10.1016/j.parkreldis.2019.10.027
  7. Diana Miranda; Joana Breda; Rita Cardoso; Nilza Gonçalves; Ana Castro Caldas; Joaquim J. Ferreira. "Should the Energy Contribution of Commercial Thickeners Be Considered in the Nutrition Plan of Patients With Dysphagia?". Nutrition in Clinical Practice (2019): https://doi.org/10.1002/ncp.10408.
    10.1002/ncp.10408
  8. Miguel Leal Rato; Gonçalo S. Duarte; Afonso N. Ferreira; Mariana Alves; Beatrice Mainoli; Tiago Teodoro; Tiago A. Mestre; João Costa; Joaquim J. Ferreira. "Nocebo response in Parkinson's disease: A systematic review and meta-analysis". Parkinsonism & Related Disorders 65 (2019): 13-19. https://doi.org/10.1016/j.parkreldis.2019.04.015.
    10.1016/j.parkreldis.2019.04.015
  9. Margherita Fabbri; Maurizio Zibetti; Giulia Ferrero; Anna Accornero; Isabel Guimaraes; Mario Giorgio Rizzone; Alberto Romagnolo; Joaquim J. Ferreira; Leonardo Lopiano. "Is lowering stimulation frequency a feasible option for subthalamic deep brain stimulation in Parkinson's disease patients with dysarthria?". Parkinsonism & Related Disorders 64 (2019): 242-248. https://doi.org/10.1016/j.parkreldis.2019.04.018.
    10.1016/j.parkreldis.2019.04.018
  10. Gonçalo Silva Duarte; Afonso Nunes-Ferreira; Filipe Brogueira Rodrigues; Fausto J Pinto; Joaquim J Ferreira; Joao Costa; Daniel Caldeira. "Morphine in acute coronary syndrome: systematic review and meta-analysis". BMJ Open (2019): https://doi.org/10.1136/bmjopen-2018-025232.
    10.1136/bmjopen-2018-025232
  11. Márcia Duarte; Raquel Bouça-Machado; Josefa Domingos; Catarina Godinho; Joaquim J. Ferreira. "Feasibility of using risk prompts to prevent falls, dehydration and pulmonary aspiration in nursing homes: a clinical study protocol". Pilot and Feasibility Studies 4 1 (2018): https://doi.org/10.1186/s40814-018-0236-1.
    10.1186/s40814-018-0236-1
  12. Gonçalo S. Duarte; Filipe B. Rodrigues; Joaquim J. Ferreira; João Costa. "Adverse events with botulinum toxin treatment in cervical dystonia: How much should we blame placebo?". Parkinsonism & Related Disorders 56 (2018): 16-19. https://doi.org/10.1016/j.parkreldis.2018.06.017.
    10.1016/j.parkreldis.2018.06.017
  13. Filipe B. Rodrigues; Joaquim J. Ferreira; Edward J. Wild. "Physician perception versus true efficacy of tetrabenazine for Huntington’s disease". Current Medical Research and Opinion 34 9 (2018): 1537-1538. https://doi.org/10.1080/03007995.2018.1490703.
    10.1080/03007995.2018.1490703
  14. Rita Cardoso; Isabel Guimarães; Helena Santos; Rita Loureiro; Josefa Domingos; Daisy Abreu; Nilza Gonçalves; Serge Pinto; Joaquim J Ferreira. "Psychosocial impact of Parkinson's disease-associated dysarthria: Cross-cultural adaptation and validation of the Dysarthria Impact Profile into European Portuguese". Geriatrics & Gerontology International (2018): https://doi.org/10.1111/ggi.13255.
    10.1111/ggi.13255
  15. Daniel Caldeira; Raquel Rodrigues; Daisy Abreu; Ana Marta Anes; Mário M. Rosa; Joaquim J. Ferreira. "Suspected adverse drug reaction reports with oral anticoagulants in Portugal: a pharmacovigilance study". Expert Opinion on Drug Safety (2018): 1-7. https://doi.org/10.1080/14740338.2018.1439474.
    10.1080/14740338.2018.1439474
  16. Ana Castro Caldas; Tiago Teodoro; Joaquim J Ferreira. "The launch of opicapone for Parkinson’s disease: negatives versus positives". Expert Opinion on Drug Safety (2018): https://doi.org/10.1080/14740338.2018.1433659.
    10.1080/14740338.2018.1433659
  17. G. Tamás; C. Abrantes; A. Valadas; P. Radics; A. Albanese; M. A. J. Tijssen; J. J. Ferreira. "Quality and reporting of guidelines on the diagnosis and management of dystonia". European Journal of Neurology 25 2 (2018): 275-283. https://doi.org/10.1111/ene.13488.
    10.1111/ene.13488
  18. R. M. Simões; A. Castro Caldas; J. J. Ferreira. "Comments on: ‘Pyridostigmine bromide versus fludrocortisone in the treatment of orthostatic hypotension in Parkinson's disease - a randomized controlled trial’". European Journal of Neurology (2018): https://doi.org/10.1111/ene.13475.
    10.1111/ene.13475
  19. Andrew J. Lees; Joaquim Ferreira; Olivier Rascol; Heinz Reichmann; Fabrizio Stocchi; Eduardo Tolosa; Werner Poewe. "Opicapone for the management of end-of-dose motor fluctuations in patients with Parkinson’s disease treated with L-DOPA". Expert Review of Neurotherapeutics 17 7 (2017): 649-659. https://doi.org/10.1080/14737175.2017.1336086.
    10.1080/14737175.2017.1336086
  20. Maetzler, W.; Domingos, J.; Srulijes, K.; Ferreira, J.J.; Bloem, B.R.. "Quantitative wearable sensors for objective assessment of Parkinson's disease". Movement Disorders 28 12 (2013): 1628-1637. http://www.scopus.com/inward/record.url?eid=2-s2.0-84886387501&partnerID=MN8TOARS.
    10.1002/mds.25628
  21. Pita Lobo, P.; Coelho, M.; Mestre, T.A.; Rosa, M.M.; Ferreira, J.J.. "Wearing-off phenomena and levodopa-induced dyskinesias in posttraumatic hemiparkinsonism". Movement Disorders 28 9 (2013): 1212-1214. http://www.scopus.com/inward/record.url?eid=2-s2.0-84883550892&partnerID=MN8TOARS.
    10.1002/mds.25556
  22. Teodoro, T.; Neutel, D.; Lobo, P.; Geraldo, A.F.; Conceição, I.; Rosa, M.M.; Albuquerque, L.; Ferreira, J.J.. "Recovery after copper-deficiency myeloneuropathy in Wilson's disease". Journal of Neurology 260 7 (2013): 1917-1918. http://www.scopus.com/inward/record.url?eid=2-s2.0-84880285586&partnerID=MN8TOARS.
    10.1007/s00415-013-6963-6
  23. Caldeira, D.; Fernandes, R.M.; Costa, J.; David, C.; Sampaio, C.; Ferreira, J.J.. "Branded versus generic clopidogrel in cardiovascular diseases: A systematic review". Journal of Cardiovascular Pharmacology 61 4 (2013): 277-282. http://www.scopus.com/inward/record.url?eid=2-s2.0-84876412183&partnerID=MN8TOARS.
    10.1097/FJC.0b013e31827e5c60
  24. Ferreira, J.J.; Neutel, D.; Mestre, T.A.; Galitzky, M.; Thalamas, C.; Santos, A.T.; Sampaio, C.; Rascol, O.. "Usefulness of OSLER test in Parkinson's disease". Sleep Medicine 14 3 (2013): 297-298. http://www.scopus.com/inward/record.url?eid=2-s2.0-84874257436&partnerID=MN8TOARS.
    10.1016/j.sleep.2012.09.005
  25. Ferreira, J.J.; Katzenschlager, R.; Bloem, B.R.; Bonuccelli, U.; Burn, D.; Deuschl, G.; Dietrichs, E.; et al. "Summary of the recommendations of the EFNS/MDS-ES review on therapeutic management of Parkinson's disease". European Journal of Neurology 20 1 (2013): 5-15. http://www.scopus.com/inward/record.url?eid=2-s2.0-84871664480&partnerID=MN8TOARS.
    10.1111/j.1468-1331.2012.03866.x
  26. Domingos, J.; Coelho, M.; Ferreira, J.J.. "Referral to rehabilitation in parkinson'S disease: Who, when and to what end? | Critérios de encaminhamento para a reabilitação na doença de parkinson: Quem, quando e que finalidade?". Arquivos de Neuro-Psiquiatria 71 12 (2013): 967-972. http://www.scopus.com/inward/record.url?eid=2-s2.0-84890639459&partnerID=MN8TOARS.
    10.1590/0004-282X20130209
  27. Albuquerque, L.; Coelho, M.; Martins, M.; Guedes, L.C.; Rosa, M.M.; Ferreira, J.J.; Cattoni, M.B.; et al. "STN-DBS does not change emotion recognition in advanced Parkinson's disease". Parkinsonism and Related Disorders (2013): http://www.scopus.com/inward/record.url?eid=2-s2.0-84886103146&partnerID=MN8TOARS.
    10.1016/j.parkreldis.2013.10.010
  28. Caldeira, D.; Fernandes, R.M.; David, C.; Costa, J.; Ferreira, J.J.. "Warfarin, acetylsalicylic acid and risk of incident atrial fibrillation in patients with heart failure and sinus rhythm: A meta-analysis". International Journal of Cardiology 168 5 (2013): 4842-4843. http://www.scopus.com/inward/record.url?eid=2-s2.0-84886444475&partnerID=MN8TOARS.
    10.1016/j.ijcard.2013.07.033
  29. Caldeira, D.; Martins, C.; Alves, L.B.; Pereira, H.; Ferreira, J.J.; Costa, J.. "Caffeine does not increase the risk of atrial fibrillation: A systematic review and meta-analysis of observational studies". Heart 99 19 (2013): 1383-1389. http://www.scopus.com/inward/record.url?eid=2-s2.0-84883827224&partnerID=MN8TOARS.
    10.1136/heartjnl-2013-303950
  30. Zhang, L.; Quadri, M.; Guedes, L.C.; Coelho, M.; Valadas, A.; Mestre, T.; Lobo, P.P.; et al. "Comprehensive LRRK2 and GBA screening in Portuguese patients with Parkinson's disease: Identification of a new family with the LRRK2 p.Arg1441His mutation and novel missense variants". Parkinsonism and Related Disorders 19 10 (2013): 897-900. http://www.scopus.com/inward/record.url?eid=2-s2.0-84883290105&partnerID=MN8TOARS.
    10.1016/j.parkreldis.2013.05.003
  31. Mestre, T.A.; Lang, A.E.; Ferreira, J.J.. "Associated movement disorders in orthostatic tremor (Journal of Neurology, Neurosurgery and Psychiatry (2012) 83, (725-729) DOI: 10.1136/jnnp-2012- 302436corr1)". Journal of Neurology, Neurosurgery and Psychiatry 83 11 (2012): http://www.scopus.com/inward/record.url?eid=2-s2.0-84867357678&partnerID=MN8TOARS.
    10.1136/jnnp-2012-302468
  32. Ferreira, J.J.; Bhidayasiri, R.; Colosimo, C.; Marti, M.J.; Zakine, B.; Maisonobe, P.. "Survey of practices employed by neurologists for the definition and management of secondary nonresponse to botulinum toxin in cervical dystonia". Functional Neurology 27 4 (2012): 225-230. http://www.scopus.com/inward/record.url?eid=2-s2.0-84876436264&partnerID=MN8TOARS.
  33. Chinnapongse, R.B.; Lew, M.F.; Ferreira, J.J.; Gullo, K.L.; Nemeth, P.R.; Zhang, Y.. "Immunogenicity and long-term efficacy of botulinum toxin type B in the treatment of cervical dystonia: Report of 4 prospective, multicenter trials". Clinical Neuropharmacology 35 5 (2012): 215-223. http://www.scopus.com/inward/record.url?eid=2-s2.0-84866545340&partnerID=MN8TOARS.
    10.1097/WNF.0b013e318263163c
  34. Coelho, M.; Ferreira, J.J.. "Late-stage Parkinson disease". Nature Reviews Neurology 8 8 (2012): 435-442. http://www.scopus.com/inward/record.url?eid=2-s2.0-84865029459&partnerID=MN8TOARS.
    10.1038/nrneurol.2012.126
  35. Rascol, O.; Ferreira, J.; Nègre-Pages, L.; Perez-Lloret, S.; Lacomblez, L.; Galitzky, M.; Lemarié, J.-C.; et al. "A proof-of-concept, randomized, placebo-controlled, multiple cross-overs (n-of-1) study of naftazone in Parkinson's disease". Fundamental and Clinical Pharmacology 26 4 (2012): 557-564. http://www.scopus.com/inward/record.url?eid=2-s2.0-84863537048&partnerID=MN8TOARS.
    10.1111/j.1472-8206.2011.00951.x
  36. Mestre, T.A.; Lang, A.E.; Ferreira, J.J.; Almeida, V.; De Carvalho, M.; Miyasaki, J.; Chen, R.; Fox, S.. "Associated movement disorders in orthostatic tremor". Journal of Neurology, Neurosurgery and Psychiatry 83 7 (2012): 725-729. http://www.scopus.com/inward/record.url?eid=2-s2.0-84861913675&partnerID=MN8TOARS.
    10.1136/jnnp-2012-302436
  37. Mestre, T.A.; Ferreira, J.J.. "An evidence-based approach in the treatment of Huntington's disease". Parkinsonism and Related Disorders 18 4 (2012): 316-320. http://www.scopus.com/inward/record.url?eid=2-s2.0-84860385532&partnerID=MN8TOARS.
    10.1016/j.parkreldis.2011.10.021
  38. Rodrigues, S.M.; De Carvalho, M.; Mestre, T.; Ferreira, J.J.; Coelho, M.; Peralta, R.; Vale, P.. "Paralytic shellfish poisoning due to ingestion of Gymnodinium catenatum contaminated cockles - Application of the AOAC HPLC Official Method". Toxicon 59 5 (2012): 558-566. http://www.scopus.com/inward/record.url?eid=2-s2.0-84857218220&partnerID=MN8TOARS.
    10.1016/j.toxicon.2012.01.004
  39. Martins, M.; Rosa, A.; Guedes, L.C.; Fonseca, B.V.; Gotovac, K.; Violante, S.; Mestre, T.; et al. "Convergence of mirna expression profiling, a-synuclein interacton and GWAS in Parkinson's disease". PLoS ONE 6 10 (2011): http://www.scopus.com/inward/record.url?eid=2-s2.0-80053925209&partnerID=MN8TOARS.
    10.1371/journal.pone.0025443
  40. Teodoro, T.; Pires, D.; Rosa, M.M.; Coelho, M.; Sampaio, C.; Ferreira, J.J.. "Has "levodopa-induced neuropathy" been reported in Parkinson's disease clinical trials?". Movement Disorders 26 10 (2011): 1966-1967. http://www.scopus.com/inward/record.url?eid=2-s2.0-80052263786&partnerID=MN8TOARS.
    10.1002/mds.23760
  41. Reimão, S.; Morgado, C.; Neto, L.; Ferreira, J.; Coelho, M.; Rosa, M.; Campos, J.. "Diffusion tensor imaging in movement disorders: Review of major patterns and correlation with normal brainstem/cerebellar white matter". Neuroradiology Journal 24 2 (2011): 177-186. http://www.scopus.com/inward/record.url?eid=2-s2.0-79958782199&partnerID=MN8TOARS.
  42. Goetz, C.G.; Stebbins, G.T.; Theeuwes, A.; Stocchi, F.; Ferreira, J.J.; van de Witte, S.; Bronzova, J.. "Temporal stability of the Unified Dyskinesia Rating Scale". Movement Disorders 26 14 (2011): 2556-2559. http://www.scopus.com/inward/record.url?eid=2-s2.0-83555179184&partnerID=MN8TOARS.
    10.1002/mds.23931
  43. Valadas, A.; Coelho, M.; Mestre, T.; Guedes, L.C.; Finisterra, M.; Noronha, A.; Rosa, M.M.; Sampaio, C.; Ferreira, J.J.. "What motivates Parkinson's disease patients to enter clinical trials?". Parkinsonism and Related Disorders 17 9 (2011): 667-671. http://www.scopus.com/inward/record.url?eid=2-s2.0-80054872611&partnerID=MN8TOARS.
    10.1016/j.parkreldis.2011.05.023
  44. Högl, B.; Arnulf, I.; Comella, C.; Ferreira, J.; Iranzo, A.; Tilley, B.; Trenkwalder, C.; et al. "Scales to assess sleep impairment in Parkinson's disease: Critique and recommendations". Movement Disorders 25 16 (2010): 2704-2716. http://www.scopus.com/inward/record.url?eid=2-s2.0-78650195329&partnerID=MN8TOARS.
    10.1002/mds.23190
  45. Ferreira, J.J.; Rascol, O.; Poewe, W.; Sampaio, C.; Rocha, J.-F.; Nunes, T.; Almeida, L.; Soares-Da-Silva, P.. "A double-blind, randomized, placebo and active-controlled study of nebicapone for the treatment of motor fluctuations in parkinson's disease". CNS Neuroscience and Therapeutics 16 6 (2010): 337-347. http://www.scopus.com/inward/record.url?eid=2-s2.0-78649267775&partnerID=MN8TOARS.
    10.1111/j.1755-5949.2010.00145.x
  46. Sampaio, C.; Ferreira, J.J.. "Parkinson disease: Adjunctive entacapone therapy increases risk of dyskinesia". Nature Reviews Neurology 6 11 (2010): 590-591. http://www.scopus.com/inward/record.url?eid=2-s2.0-78149398961&partnerID=MN8TOARS.
    10.1038/nrneurol.2010.158
  47. Oertel, W.H.; Berardelli, A.; Bloem, B.R.; Bonuccelli, U.; Burn, D.; Deuschl, G.; Dietrichs, E.; et al. "Late (Complicated) Parkinson's Disease". European Handbook of Neurological Management: Second Edition 1 (2010): 237-267. http://www.scopus.com/inward/record.url?eid=2-s2.0-84885562994&partnerID=MN8TOARS.
    10.1002/9781444328394.ch15
  48. Oertel, W.H.; Berardelli, A.; Bloem, B.R.; Bonuccelli, U.; Burn, D.; Deuschl, G.; Dietrichs, E.; et al. "Early (Uncomplicated) Parkinson's Disease". European Handbook of Neurological Management: Second Edition 1 (2010): 217-236. http://www.scopus.com/inward/record.url?eid=2-s2.0-84855302877&partnerID=MN8TOARS.
    10.1002/9781444328394.ch14
  49. Coelho, M.; Marti, M.J.; Tolosa, E.; Ferreira, J.J.; Valldeoriola, F.; Rosa, M.; Sampaio, C.. "Late-stage Parkinson's disease: The Barcelona and Lisbon cohort". Journal of Neurology 257 9 (2010): 1524-1532. http://www.scopus.com/inward/record.url?eid=2-s2.0-77957332171&partnerID=MN8TOARS.
    10.1007/s00415-010-5566-8
  50. Rosa, M.M.; Ferreira, J.J.; Coelho, M.; Freire, R.; Sampaio, C.. "Prescribing patterns of antiparkinsonian agents in Europe". Movement Disorders 25 8 (2010): 1053-1060. http://www.scopus.com/inward/record.url?eid=2-s2.0-77953504783&partnerID=MN8TOARS.
    10.1002/mds.23038
  51. Correia Guedes, L.; Ferreira, J.J.; Rosa, M.M.; Coelho, M.; Bonifati, V.; Sampaio, C.. "Worldwide frequency of G2019S LRRK2 mutation in Parkinson's disease: A systematic review". Parkinsonism and Related Disorders 16 4 (2010): 237-242. http://www.scopus.com/inward/record.url?eid=2-s2.0-77952888334&partnerID=MN8TOARS.
    10.1016/j.parkreldis.2009.11.004
  52. Louis, E.D.; Ferreira, J.J.. "How common is the most common adult movement disorder? Update on the worldwide prevalence of essential tremor". Movement Disorders 25 5 (2010): 534-541. http://www.scopus.com/inward/record.url?eid=2-s2.0-77951230101&partnerID=MN8TOARS.
    10.1002/mds.22838
  53. Mestre, T.; Ferreira, J.J.. "Pharmacotherapy in Parkinsongs disease: Case studies". Therapeutic Advances in Neurological Disorders 3 2 (2010): 117-126. http://www.scopus.com/inward/record.url?eid=2-s2.0-77953423881&partnerID=MN8TOARS.
    10.1177/1756285609352366
  54. Sampaio, C.; Ferreira, J.J.. "Parkinson disease: ADAGIO trial hints that rasagiline slows disease progression". Nature Reviews Neurology 6 3 (2010): 126-128. http://www.scopus.com/inward/record.url?eid=2-s2.0-77949378919&partnerID=MN8TOARS.
    10.1038/nrneurol.2010.2
  55. Ferreira, J.J.; Neutel, D.; Mestre, T.; Coelho, M.; Rosa, M.M.; Rascol, O.; Sampaio, C.. "Skin cancer and Parkinson's disease". Movement Disorders 25 2 (2010): 139-148. http://www.scopus.com/inward/record.url?eid=2-s2.0-77649110091&partnerID=MN8TOARS.
    10.1002/mds.22855
  56. Coelho, M.; Valadas, A.F.; Mestre, T.; Ferreira, J.J.. "Pain and quality of life in the treatment of cervical dystonia". European Neurological Review 4 2 (2009): 74-78. http://www.scopus.com/inward/record.url?eid=2-s2.0-77958089117&partnerID=MN8TOARS.
  57. Outeiro, T.F.; Ferreira, J.. "Current and future therapeutic strategies for Parkinson's disease". Current Pharmaceutical Design 15 34 (2009): 3968-3976. http://www.scopus.com/inward/record.url?eid=2-s2.0-70649115523&partnerID=MN8TOARS.
    10.2174/138161209789649321
  58. Di Fonzo, A.; Fabrizio, E.; Thomas, A.; Fincati, E.; Marconi, R.; Tinazzi, M.; Breedveld, G.J.; et al. "GIGYF2 mutations are not a frequent cause of familial Parkinson's disease". Parkinsonism and Related Disorders 15 9 (2009): 703-705. http://www.scopus.com/inward/record.url?eid=2-s2.0-70350276499&partnerID=MN8TOARS.
    10.1016/j.parkreldis.2009.05.001
  59. Gouveia, L.O.; Castanho, P.; Ferreira, J.. "To the editor". Spine 34 22 (2009): 2476-2477. http://www.scopus.com/inward/record.url?eid=2-s2.0-78751483037&partnerID=MN8TOARS.
    10.1097/BRS.0b013e3181b96ef2
  60. Mestre, T.; Ferreira, J.; Coelho, M.M.; Rosa, M.; Sampaio, C.. "Therapeutic interventions for symptomatic treatment in Huntington's disease". Cochrane Database of Systematic Reviews 3 (2009): http://www.scopus.com/inward/record.url?eid=2-s2.0-70049083077&partnerID=MN8TOARS.
    10.1002/14651858.CD006456.pub2
  61. Mestre, T.; Ferreira, J.; Coelho, M.M.; Rosa, M.; Sampaio, C.. "Therapeutic interventions for disease progression in Huntington's disease". Cochrane Database of Systematic Reviews 3 (2009): http://www.scopus.com/inward/record.url?eid=2-s2.0-70049091196&partnerID=MN8TOARS.
    10.1002/14651858.CD006455.pub2
  62. Mestre, T.; Ferreira, J.; Coelho, M.M.; Rosa, M.; Sampaio, C.. "Therapeutic interventions for symptomatic treatment in Huntington's disease.". Cochrane database of systematic reviews (Online) 3 (2009): http://www.scopus.com/inward/record.url?eid=2-s2.0-68549112836&partnerID=MN8TOARS.
  63. Mestre, T.; Ferreira, J.; Coelho, M.M.; Rosa, M.; Sampaio, C.. "Therapeutic interventions for disease progression in Huntington's disease.". Cochrane database of systematic reviews (Online) 3 (2009): http://www.scopus.com/inward/record.url?eid=2-s2.0-68549140006&partnerID=MN8TOARS.
  64. Ross, O.A.; Spanaki, C.; Griffith, A.; Lin, C.-H.; Kachergus, J.; Haugarvoll, K.; Latsoudis, H.; et al. "Haplotype analysis of Lrrk2 R1441H carriers with parkinsonism". Parkinsonism and Related Disorders 15 6 (2009): 466-467. http://www.scopus.com/inward/record.url?eid=2-s2.0-67549117509&partnerID=MN8TOARS.
    10.1016/j.parkreldis.2008.09.001
  65. Gouveia, L.O.; Castanho, P.; Ferreira, J.J.. "Safety of chiropractic interventions: A systematic review". Spine 34 11 (2009): http://www.scopus.com/inward/record.url?eid=2-s2.0-67650503611&partnerID=MN8TOARS.
    10.1097/BRS.0b013e3181a16d63
  66. Mestre, T.; Ferreira, J.J.; Jain, S.. "A multimodal approach to physical therapy in Parkinson's disease: Optimizing strategies". Movement Disorders 24 6 (2009): http://www.scopus.com/inward/record.url?eid=2-s2.0-67651166884&partnerID=MN8TOARS.
    10.1002/mds.22478
  67. Mestre, T.; Ferreira, J.J.. "Eslicarbazepine acetate: A new option for the treatment of focal epilepsy". Expert Opinion on Investigational Drugs 18 2 (2009): 221-229. http://www.scopus.com/inward/record.url?eid=2-s2.0-65549110861&partnerID=MN8TOARS.
    10.1517/13543780802635107
  68. Costa, J.; Rocha, M.L.; Ferreira, J.; Evangelista, T.; Coelho, M.; De Carvalho, M.. "Botulinum toxin type-B improves sialorrhea and quality of life in bulbaronset amyotrophic lateral sclerosis". Journal of Neurology 255 4 (2008): 545-550. http://www.scopus.com/inward/record.url?eid=2-s2.0-42549167094&partnerID=MN8TOARS.
    10.1007/s00415-008-0738-5
  69. Fernandes, R.; Ferreira, J.J.; Sampaio, C.. "The Placebo Response in Studies of Acute Migraine". Journal of Pediatrics 152 4 (2008): http://www.scopus.com/inward/record.url?eid=2-s2.0-40749135778&partnerID=MN8TOARS.
    10.1016/j.jpeds.2007.09.024
  70. Coelho, M.; Ferreira, J.; Rosa, M.; Sampaio, C.. "Treatment options for non-motor symptoms in late-stage Parkinson's disease". Expert Opinion on Pharmacotherapy 9 4 (2008): 523-535. http://www.scopus.com/inward/record.url?eid=2-s2.0-40649125791&partnerID=MN8TOARS.
    10.1517/14656566.9.4.523
  71. Ferreira, J.J.; Almeida, L.; Cunha, L.; Ticmeanu, M.; Rosa, M.M.; Januário, C.; Mitu, C.-E.; et al. "Effects of nebicapone on levodopa pharmacokinetics, catechol-O- methyltransferase activity, and motor fluctuations in patients with Parkinson disease". Clinical Neuropharmacology 31 1 (2008): 2-18. http://www.scopus.com/inward/record.url?eid=2-s2.0-40049104890&partnerID=MN8TOARS.
    10.1097/wnf.0b013e3180645cb0
  72. Ferreira, J.J.; Finisterra, M.; Noronha, A.; Mestre, T.. "Clinical research centre as functional unit of biomedical research | Centro de investigação clínica como unidade funcional da investigação biomédica". Sinapse 8 2 (2008): 27-32. http://www.scopus.com/inward/record.url?eid=2-s2.0-56549095579&partnerID=MN8TOARS.
  73. Silveira-Moriyama, L.; Guedes, L.C.; Kingsbury, A.; Ayling, H.; Shaw, K.; Barbosa, E.R.; Bonifati, V.; et al. "Hyposmia in G2019S LRRK2-related parkinsonism: Clinical and pathologic data". Neurology 71 13 (2008): 1021-1026. http://www.scopus.com/inward/record.url?eid=2-s2.0-54049145191&partnerID=MN8TOARS.
    10.1212/01.wnl.0000326575.20829.45
  74. Healy, D.G.; Falchi, M.; O'Sullivan, S.S.; Bonifati, V.; Durr, A.; Bressman, S.; Brice, A.; et al. "Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study". The Lancet Neurology 7 7 (2008): 583-590. http://www.scopus.com/inward/record.url?eid=2-s2.0-50049104725&partnerID=MN8TOARS.
    10.1016/S1474-4422(08)70117-0
  75. Stowe, R.L.; Ives, N.J.; Clarke, C.; Van Hilten, J.; Ferreira, J.; Hawker, R.J.; Shah, L.; Wheatley, K.; Gray, R.. "Dopamine agonist therapy in early Parkinson's disease". Cochrane Database of Systematic Reviews 2 (2008): http://www.scopus.com/inward/record.url?eid=2-s2.0-44949176630&partnerID=MN8TOARS.
    10.1002/14651858.CD006564.pub2
  76. Mestre, T.; Coelho, M.; Costa, J.; Ferreira, J.J.; Rosa, M.; Sampaio, C.. "Therapeutic interventions for symptomatic treatment in Huntington's disease". Cochrane Database of Systematic Reviews 2 (2007): http://www.scopus.com/inward/record.url?eid=2-s2.0-44949167557&partnerID=MN8TOARS.
    10.1002/14651858.CD006456
  77. Ferreira, J.J.; Mestre, T.; Hewett, R.M.; Coelho, M.; Rosa, M.M.; Rascol, O.; Sampaio, C.. "Therapeutic interventions for daytime somnolence in Parkinson's disease". Cochrane Database of Systematic Reviews 4 (2007): http://www.scopus.com/inward/record.url?eid=2-s2.0-44949088704&partnerID=MN8TOARS.
    10.1002/14651858.CD006808
  78. Neutel, D.; Ferreira, J.J.; Coelho, M.; Rosa, M.M.; Rascol, O.; Sampaio, C.. "Piribedil for levodopa-induced complications in Parkinson's disease". Cochrane Database of Systematic Reviews 3 (2007): http://www.scopus.com/inward/record.url?eid=2-s2.0-44949248317&partnerID=MN8TOARS.
    10.1002/14651858.CD006707
  79. Neutel, D.; Ferreira, J.J.; Coelho, M.; Rosa, M.M.; Rascol, O.; Sampaio, C.. "Piribedil for symptomatic management of Parkinson's disease". Cochrane Database of Systematic Reviews 3 (2007): http://www.scopus.com/inward/record.url?eid=2-s2.0-44949152616&partnerID=MN8TOARS.
    10.1002/14651858.CD006708
  80. Ferreira, J.J.; Mestre, T.; Hewett, R.M.; Coelho, M.; Rosa, M.M.; Rascol, O.; Sampaio, C.. "Therapeutic interventions for sleep disorders in Parkinson's disease". Cochrane Database of Systematic Reviews 4 (2007): http://www.scopus.com/inward/record.url?eid=2-s2.0-44949251014&partnerID=MN8TOARS.
    10.1002/14651858.CD006809
  81. Mestre, T.; Coelho, M.M.; Costa, J.; Ferreira, J.; Rosa, M.; Sampaio, C.. "Therapeutic interventions for disease progression in Huntington's disease". Cochrane Database of Systematic Reviews 2 (2007): http://www.scopus.com/inward/record.url?eid=2-s2.0-44949232145&partnerID=MN8TOARS.
    10.1002/14651858.CD006455
  82. Neutel, D.; Ferreira, J.J.; Coelho, M.; Rosa, M.M.; Rascol, O.; Sampaio, C.. "Piribedil versus levodopa in early Parkinson's disease". Cochrane Database of Systematic Reviews 3 (2007): http://www.scopus.com/inward/record.url?eid=2-s2.0-44949252179&partnerID=MN8TOARS.
    10.1002/14651858.CD006710
  83. Gouveia, L.O.; Castanho, P.; Ferreira, J.J.; Guedes, M.M.; Falcão, F.; Melo, T.P.e.. "Chiropractic manipulation: Reasons for concern?". Clinical Neurology and Neurosurgery 109 10 (2007): 922-925. http://www.scopus.com/inward/record.url?eid=2-s2.0-35349001077&partnerID=MN8TOARS.
    10.1016/j.clineuro.2007.08.004
  84. Coelho, M.; Ferreira, J.; Sampaio, C.. "Parkinson's Disease". Evidence-based Neurology: Management of Neurological Disorders (2007): 199-220. http://www.scopus.com/inward/record.url?eid=2-s2.0-84891019934&partnerID=MN8TOARS.
    10.1002/9780470988350.ch20
  85. Fonseca, A.C.; Ferreira, J.J.; Albuquerque, L.; Ferro, J.M.. "Sneeze as a precipitating factor of cerebral venous thrombosis [5]". European Journal of Neurology 14 10 (2007): http://www.scopus.com/inward/record.url?eid=2-s2.0-34648830248&partnerID=MN8TOARS.
    10.1111/j.1468-1331.2007.01914.x
  86. De Carvalho, M.; Costa, J.; Ferreira, J.. "Reply from the authors [2]". Neurology 69 13 (2007): http://www.scopus.com/inward/record.url?eid=2-s2.0-34748904165&partnerID=MN8TOARS.
    10.1212/01.wnl.0000286557.14108.1c
  87. Ferreira, J.; Silva, J.M.; Freire, R.; Pignatelli, J.; Guedes, L.C.; Feijó, A.; Rosa, M.M.; et al. "Skin cancers and precancerous lesions in Parkinson's disease patients". Movement Disorders 22 10 (2007): 1471-1475. http://www.scopus.com/inward/record.url?eid=2-s2.0-34548021467&partnerID=MN8TOARS.
    10.1002/mds.21575
  88. De Carvalho, M.; Costa, J.; Ferreira, J.. "Reply from the authors [6]". Neurology 69 1 (2007): http://www.scopus.com/inward/record.url?eid=2-s2.0-34347405911&partnerID=MN8TOARS.
    10.1212/01.wnl.0000270099.87599.77
  89. Ferreira, J.J.; Guedes, L.C.; Rosa, M.M.; Coelho, M.; Van Doeselaar, M.; Schweiger, D.; Di Fonzo, A.; et al. "High prevalence of LRRK2 mutations in familial and sporadic Parkinson's disease in Portugal". Movement Disorders 22 8 (2007): 1194-1201. http://www.scopus.com/inward/record.url?eid=2-s2.0-34250330484&partnerID=MN8TOARS.
    10.1002/mds.21525
  90. Mestre, T.A.; Ferreira, J.J.; Pimentel, J.. "Putaminal petechial haemorrhage as the cause of non-ketotic hyperglycaemic chorea: A neuropathological case correlated with MRI findings [7]". Journal of Neurology, Neurosurgery and Psychiatry 78 5 (2007): 549-550. http://www.scopus.com/inward/record.url?eid=2-s2.0-34247252474&partnerID=MN8TOARS.
    10.1136/jnnp.2006.105387
  91. Di Fonzo, A.; Chien, H.F.; Socal, M.; Giraudo, S.; Tassorelli, C.; Iliceto, G.; Fabbrini, G.; et al. "ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease". Neurology 68 19 (2007): 1557-1562. http://www.scopus.com/inward/record.url?eid=2-s2.0-34248182509&partnerID=MN8TOARS.
    10.1212/01.wnl.0000260963.08711.08
  92. Ferreira, J.J.; Costa, J.; Coelho, M.; Sampaio, C.. "The management of cervical dystonia". Expert Opinion on Pharmacotherapy 8 2 (2007): 129-140. http://www.scopus.com/inward/record.url?eid=2-s2.0-33846849251&partnerID=MN8TOARS.
    10.1517/14656566.8.2.129
  93. Costa, J.; Henriques, R.; Barroso, C.; Ferreira, J.; Atalaia, A.; De Carvalho, M.. "Upper limb tremor induced by peripheral nerve injury". Neurology 67 10 (2006): 1884-1886. http://www.scopus.com/inward/record.url?eid=2-s2.0-33845401610&partnerID=MN8TOARS.
    10.1212/01.wnl.0000244437.31413.2b
  94. Schrag, A.; Geser, F.; StampferKountchev, M.; Seppi, K.; Sawires, M.; Köllensperger, M.; Scherfler, C.; et al. "Health-related quality of life in multiple system atrophy". Movement Disorders 21 6 (2006): 809-815. http://www.scopus.com/inward/record.url?eid=2-s2.0-33745869469&partnerID=MN8TOARS.
    10.1002/mds.20808
  95. Castro-Caldas, A.; Delwaide, P.; Jost, W.; Merello, M.; Williams, A.; Lamberti, P.; Aguilar, M.; et al. "The Parkinson-control study: A 1-year randomize, double-blind trial comapring piribedil (150 mg/day) with bromocriptine (25 mg/day) in early combination with levodopa in Parkinson's disease". Movement Disorders 21 4 (2006): 500-509. http://www.scopus.com/inward/record.url?eid=2-s2.0-33646238464&partnerID=MN8TOARS.
    10.1002/mds.20750
  96. Ferreira, J.J.; Desboeuf, K.; Galitzky, M.; Thalamas, C.; Brefel-Courbon, C.; Fabre, N.; Senard, J.-M.; et al. "Sleep disruption, daytime somnolence and 'sleep attacks' in Parkinson's disease: A clinical survey in PD patients and age-matched healthy volunteers". European Journal of Neurology 13 3 (2006): 209-214. http://www.scopus.com/inward/record.url?eid=2-s2.0-33645312090&partnerID=MN8TOARS.
    10.1111/j.1468-1331.2006.01262.x
  97. Di Fonzo, A.; Tassorelli, C.; De Mari, M.; Chien, H.F.; Ferreira, J.; Rohé, C.F.; Riboldazzi, G.; et al. "Comprehensive analysis of the LRRK2 gene in sixty families with Parkinson's disease". European Journal of Human Genetics 14 3 (2006): 322-331. http://www.scopus.com/inward/record.url?eid=2-s2.0-33645139675&partnerID=MN8TOARS.
    10.1038/sj.ejhg.5201539
  98. Geser, F.; Wenning, G.K.; Seppi, K.; Stampfer-Kountchev, M.; Scherfler, C.; Sawires, M.; Frick, C.; et al. "Progression of multiple system atrophy (MSA): A prospective natural history study by the European MSA study group (EMSA SG)". Movement Disorders 21 2 (2006): 179-186. http://www.scopus.com/inward/record.url?eid=2-s2.0-33644947758&partnerID=MN8TOARS.
    10.1002/mds.20678
  99. Ferreira, J.J.; Couto, M.; Costa, J.; Coelho, M.; Rosa, M.M.; Sampaio, C.. "Botulinum toxin for the treatment of pain syndromes | Toxina botulínica para o tratamento de síndromas dolorosas.". Acta reumatológica portuguesa 31 1 (2006): 49-62. http://www.scopus.com/inward/record.url?eid=2-s2.0-34447546438&partnerID=MN8TOARS.
  100. Costa, J.; Espírito-Santo, C.; Borges, A.; Ferreira, J.J.; Coelho, M.; Moore, P.; Sampaio, C.. "Botulinum toxin type B for cervical dystonia.". Cochrane database of systematic reviews (Online) 1 (2005): http://www.scopus.com/inward/record.url?eid=2-s2.0-19044365570&partnerID=MN8TOARS.
  101. Costa, J.; Borges, A.; Espírito-Santo, C.; Ferreira, J.; Coelho, M.; Moore, P.; Sampaio, C.. "Botulinum toxin type A versus botulinum toxin type B for cervical dystonia.". Cochrane database of systematic reviews (Online : Update Software) 1 (2005): http://www.scopus.com/inward/record.url?eid=2-s2.0-18944394419&partnerID=MN8TOARS.
  102. Costa, J.; Espírito-Santo, C.; Borges, A.; Ferreira, J.J.; Coelho, M.; Moore, P.; Sampaio, C.. "Botulinum toxin type A therapy for blepharospasm.". Cochrane database of systematic reviews (Online) 1 (2005): http://www.scopus.com/inward/record.url?eid=2-s2.0-18944399965&partnerID=MN8TOARS.
  103. Costa, J.; Espírito-Santo, C.; Borges, A.; Ferreira, J.J.; Coelho, M.; Sampaio, C.. "Botulinum toxin type A versus anticholinergics for cervical dystonia.". Cochrane database of systematic reviews (Online : Update Software) 1 (2005): http://www.scopus.com/inward/record.url?eid=2-s2.0-18944405867&partnerID=MN8TOARS.
  104. Costa, J.; Espírito-Santo, C.; Borges, A.; Ferreira, J.J.; Coelho, M.; Moore, P.; Sampaio, C.. "Botulinum toxin type A therapy for hemifacial spasm.". Cochrane database of systematic reviews (Online) 1 (2005): http://www.scopus.com/inward/record.url?eid=2-s2.0-18944390183&partnerID=MN8TOARS.
  105. Costa, J.; Espírito-Santo, C.; Borges, A.; Ferreira, J.J.; Coelho, M.; Moore, P.; Sampaio, C.. "Botulinum toxin type A therapy for cervical dystonia.". Cochrane database of systematic reviews (Online) 1 (2005): http://www.scopus.com/inward/record.url?eid=2-s2.0-18944375202&partnerID=MN8TOARS.
  106. Ferreira, J.; Sampaio, C.. "Essential tremor.". Clinical evidence. 13 (2005): 1608-1621. http://www.scopus.com/inward/record.url?eid=2-s2.0-33644816671&partnerID=MN8TOARS.
  107. Di Fonzo, A.; Rohé, C.F.; Ferreira, J.; Chien, H.F.; Vacca, L.; Stocchi, F.; Guedes, L.; et al. "A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease". Lancet 365 9457 (2005): 412-415. http://www.scopus.com/inward/record.url?eid=2-s2.0-19944431081&partnerID=MN8TOARS.
    10.1016/S0140-6736(05)17829-5
  108. Geser, F.; Seppi, K.; Stampfer-Kountchev, M.; Köllensperger, M.; Diem, A.; Ndayisaba, J.P.; Ostergaard, K.; et al. "The European Multiple System Atrophy-Study Group (EMSA-SG)". Journal of Neural Transmission 112 12 (2005): 1677-1686. http://www.scopus.com/inward/record.url?eid=2-s2.0-27744545323&partnerID=MN8TOARS.
    10.1007/s00702-005-0328-y
  109. Goldwurm, S.; Di Fonzo, A.; Simons, E.J.; Rohé, C.F.; Zini, M.; Canesi, M.; Tesei, S.; et al. "The G6055A (G2019S) mutation in LRRK2 is frequent in both early and late onset Parkinson's disease and originates from a common ancestor.". Journal of medical genetics. 42 11 (2005): http://www.scopus.com/inward/record.url?eid=2-s2.0-33645160640&partnerID=MN8TOARS.
  110. Costa, J.; Espírito-Santo, C.; Borges, A.; Ferreira, J.J.; Coelho, M.; Moore, P.; Sampaio, C.. "Botulinum toxin type B therapy for cervical dystonia | Botulinumtoxin Typ B zur Behandlung der zervikalen Dystonie". Praxis 94 35 (2005): 1349-1350. http://www.scopus.com/inward/record.url?eid=2-s2.0-80051711243&partnerID=MN8TOARS.
    10.1024/0369-8394.94.35.1349
  111. Sampaio, C.; Costa, J.; Ferreira, J.J.. "Clinical comparability of marketed formulations of botulinum toxin". Movement Disorders 19 SUPPL. 8 (2004): http://www.scopus.com/inward/record.url?eid=2-s2.0-3242745955&partnerID=MN8TOARS.
  112. Ferreira, J.; Sampaio, C.. "Essential tremor.". Clinical evidence 11 (2004): 1674-1686. http://www.scopus.com/inward/record.url?eid=2-s2.0-17544381814&partnerID=MN8TOARS.
  113. Coelho, M.; Ferreira, J.J.; Dias, B.; Sampaio, C.; Pavão Martins, I.; Castro-Caldas, A.. "Assessment of time perception: The effect of aging". Journal of the International Neuropsychological Society 10 3 (2004): 332-341. http://www.scopus.com/inward/record.url?eid=2-s2.0-2942695873&partnerID=MN8TOARS.
    10.1017/S1355617704103019
  114. Ferreira, J.; Sampaio, C.. "Essential tremor.". Clinical evidence 9 (2003): 1421-1431. http://www.scopus.com/inward/record.url?eid=2-s2.0-5444249841&partnerID=MN8TOARS.
  115. Rascol, O.; Payoux, P.; Ory, F.; Ferreira, J.J.; Brefel-Courbon, C.; Montastruc, J.-L.; Schapira; et al. "Limitations of current Parkinson's disease therapy". Annals of Neurology 53 SUPPL. 3 (2003): http://www.scopus.com/inward/record.url?eid=2-s2.0-0037378689&partnerID=MN8TOARS.
    10.1002/ana.10513
  116. Rascol, O.; Brefel-Courbon, C.; Payoux, P.; Ferreira, J.. "The management of patients with early Parkinson's disease.". Advances in neurology 91 (2003): 203-211. http://www.scopus.com/inward/record.url?eid=2-s2.0-0037208667&partnerID=MN8TOARS.
  117. Rascol, O.; Payoux, P.; Ferreira, J.; Brefel-Courbon, C.. "The management of patients with early Parkinson's disease". Parkinsonism and Related Disorders 9 1 (2002): 61-67. http://www.scopus.com/inward/record.url?eid=2-s2.0-0036824848&partnerID=MN8TOARS.
    10.1016/S1353-8020(02)00045-7
  118. Tsuboi, Y.; Uitti, R.J.; Delisle, M.-B.; Ferreira, J.J.; Brefel-Courbon, C.; Rascol, O.; Ghetti, B.; et al. "Clinical features and disease haplotypes of individuals with the N279K tau gene mutation: A comparison of the pallidopontonigral degeneration kindred and a French family". Archives of Neurology 59 6 (2002): 943-950. http://www.scopus.com/inward/record.url?eid=2-s2.0-0036279601&partnerID=MN8TOARS.
  119. Sampaio, C.; Ferreira, J.. "Essential tremor.". Clinical evidence 7 (2002): 1169-1178. http://www.scopus.com/inward/record.url?eid=2-s2.0-0036595159&partnerID=MN8TOARS.
  120. Ferreira, J.J.; Galitzky, M.; Thalamas, C.; Tiberge, M.; Montastruc, J.L.; Sampaio, C.; Rascol, O.. "Effect of ropinirole on sleep onset: A randomized, placebo-controlled study in healthy volunteers". Neurology 58 3 (2002): 460-462. http://www.scopus.com/inward/record.url?eid=2-s2.0-0037065809&partnerID=MN8TOARS.
  121. Rascol, O.; Ferreira, J.-J.; Payoux, P.; Brefel-Courbon, Ch.; Montastruc, J.-L.. "Management of levodopa-induced dyskinesia | Prise en charge des dyskinésies par la lévodopa". Revue Neurologique 158 SUPPL. 1 (2002): http://www.scopus.com/inward/record.url?eid=2-s2.0-0142184018&partnerID=MN8TOARS.
  122. Sampaio, C.; Ferreira, J.J.; Costa, J.. "Evidence-based medicine (EBM) applied to Parkinson's disease treatment". Parkinsonism and Related Disorders 9 1 (2002): 7-13. http://www.scopus.com/inward/record.url?eid=2-s2.0-0036825207&partnerID=MN8TOARS.
    10.1016/S1353-8020(02)00039-1
  123. Rascol, O.; Ferreira, J.; Montastruc, J.-L.. "Abnormal daytime somnolence, "sleep attacks", and antiparkinson drugs | Pharmacologie: Somnolence diurne anormale, « attaques de sommeil » et médicaments antiparkinsoniens". Revue Neurologique 157 10 (2001): 1313-1323. http://www.scopus.com/inward/record.url?eid=2-s2.0-0035164048&partnerID=MN8TOARS.
  124. Costa, J.; Infante de Oliveira, E.I.; Rosa, M.M.; Ferreira, J.J.; Sampaio, C.; Vaz Carneiro, A.. "Cardiac toxicity of antidepressive tricyclic overdose: A systematic review - Part IV | Os efeitos cardíacos da intoxicação aguda por antidepressivos tricíclicos: Revisão sistemática da literatura - Parte IV". Revista Portuguesa de Cardiologia 20 10 (2001): 1021-1030. http://www.scopus.com/inward/record.url?eid=2-s2.0-0035211018&partnerID=MN8TOARS.
  125. Costa, J.; Infante De Oliveira, E.; Rosa, M.M.; Ferreira, J.J.; Sampaio, C.; Vaz Carneiro, A.. "Cardiac toxicity of antidepressant tricyclic overdose: A systematic review - Part III | Os efeitos cardíacos da intoxicação aguda por antidepressivos tricíclicos: Revisão sistemática da literatura - Parte III". Revista Portuguesa de Cardiologia 20 9 (2001): 901-909. http://www.scopus.com/inward/record.url?eid=2-s2.0-0035178748&partnerID=MN8TOARS.
  126. Costa, J.; Infante de Oliveira, E.; Rosa, M.M.; Ferreira, J.J.; Sampaio, C.; Vaz Carneiro, A.. "Cardiac toxicity of tricyclic antidepressant overdose: A systematic review - Part II | Os efeitos cardíacos da intoxicação aguda por antidepressivos tricíclicos: Revisão sistemática da literatura - Parte II". Revista Portuguesa de Cardiologia 20 7-8 (2001): 765-772. http://www.scopus.com/inward/record.url?eid=2-s2.0-19244383903&partnerID=MN8TOARS.
  127. Rascol, O.; Ferreira, J.J.; Thalamas, C.; Galitsky, M.; Montastruc, J.L.. "Dopamine agonists. Their role in the management of Parkinson's disease.". Advances in neurology 86 (2001): 301-309. http://www.scopus.com/inward/record.url?eid=2-s2.0-0035225327&partnerID=MN8TOARS.
  128. Costa, J.; Rosa, M.M.; Ferreira, J.J.; Sampaio, C.; Vaz Carneiro, A.. "Cardiac toxicity of tricyclic antidepressant overdose: A systematic review | Os efeitos cardíacos da intoxicação aguda por antidepressivos tricíclicos: Revisão sistemática da literatura. Parte I. [55]". Revista Portuguesa de Cardiologia 20 6 (2001): 671-678. http://www.scopus.com/inward/record.url?eid=2-s2.0-0034869818&partnerID=MN8TOARS.
  129. Montastruc, J.-L.; Brefel-Courbon, C.; Senard, J.-M.; Bagheri, H.; Ferreira, J.; Rascol, O.; Lapeyre-Mestre, M.. "Sleep attacks and antiparkinsonian drugs: A pilot prospective pharmacoepidemiologic study". Clinical Neuropharmacology 24 3 (2001): 181-183. http://www.scopus.com/inward/record.url?eid=2-s2.0-0034971543&partnerID=MN8TOARS.
    10.1097/00002826-200105000-00013
  130. Ferreira, J.J.; Thalamas, C.; Montastruc, J.L.; Castro-Caldas, A.; Rascol, O.. "Levodopa monotherapy can induce "sleep attacks" in Parkinson's disease patients [4]". Journal of Neurology 248 5 (2001): 426-427. http://www.scopus.com/inward/record.url?eid=2-s2.0-0035001011&partnerID=MN8TOARS.
    10.1007/s004150170188
  131. Ferreira, J.J.; Galitzky, M.; Montastruc, J.L.; Rascol, O.. "Adoptive transfer of vitiligo after allogeneic bone marrow transplantation for non-Hodgkin's lymphoma". Lancet 355 9212 (2000): 1333-1334. http://www.scopus.com/inward/record.url?eid=2-s2.0-0034654935&partnerID=MN8TOARS.
  132. Sampaio, C.; Ferreira, J.; Costa, J.. "Numbers needed for treatment and their respective confidence intervals: useful tools to assess clinical significance and uncertainty associated with medical interventions | Número que é necessário tratar e respectivos intervalos de confiança: instrumentos úteis para avaliar o significado clínico e a incerteza associados às intervenções médicas.". Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology 19 12 (2000): 1303-1308. http://www.scopus.com/inward/record.url?eid=2-s2.0-0034572944&partnerID=MN8TOARS.
  133. Warner, T.; Camfield, L.; Marsden, C.D.; Nemeth, A.H.; Hyman, N.; Harley, D.; Wissel, J.; et al. "A prevalence study of primary dystonia in eight European countries". Journal of Neurology 247 10 (2000): 787-792. http://www.scopus.com/inward/record.url?eid=2-s2.0-0033745810&partnerID=MN8TOARS.
    10.1007/s004150070094
  134. Ferreira, J.J.; Rascol, O.. "Prevention and therapeutic strategies for levodopa-induced dyskinesias in Parkinson's disease". Current Opinion in Neurology 13 4 (2000): 431-436. http://www.scopus.com/inward/record.url?eid=2-s2.0-0033864014&partnerID=MN8TOARS.
    10.1097/00019052-200008000-00011
  135. Pirker, W.; Happe, S.; Ferreira, J.; Galitzky, M.; Montastruc, J.L.; Rascol, O.. "Sleep attacks in Parkinson's disease (multiple letters)". Lancet 356 9229 (2000): 597-598. http://www.scopus.com/inward/record.url?eid=2-s2.0-0034641514&partnerID=MN8TOARS.
  136. Sampaio, C.; Ferreira, J.J.. "Cochrane Collaboration. What is it? What is it for? How does it contribute to the practice of Evidence-Based Medicine | A cochrane collaboration. o que é? Para que serve? Como contribui para a prática da medicina baseada na evidência?". Acta Medica Portuguesa 11 8-9 (1998): 739-744. http://www.scopus.com/inward/record.url?eid=2-s2.0-2542612295&partnerID=MN8TOARS.
  137. Ferreira, J.J.; Sampaio, C.. "Critical Assessment of Articles on Controlled Clinical Trials II. Results | Avaliação crítica de artigos relativos a ensaios clínicos controlados II. Resultados". Acta Medica Portuguesa 11 8-9 (1998): 755-760. http://www.scopus.com/inward/record.url?eid=2-s2.0-2542621452&partnerID=MN8TOARS.
  138. Sampaio, C.; Ferreira, J.J.. "Critical Assessment of Articles on Controlled Clinical Trials I. Planning | Avaliação crítica de artigos relativos a ensaios clínicos controlados I. Planeamento". Acta Medica Portuguesa 11 8-9 (1998): 749-754. http://www.scopus.com/inward/record.url?eid=2-s2.0-2542584751&partnerID=MN8TOARS.
  139. Ferro, J.M.; Pinto, A.N.; Falcão, I.; Rodrigues, G.; Ferreira, J.; Falcão, F.; Azevedo, E.; et al. "Diagnosis of Stroke by the Nonneurologist a validation study". Stroke 29 6 (1998): 1106-1109. http://www.scopus.com/inward/record.url?eid=2-s2.0-0031781856&partnerID=MN8TOARS.
  140. Sampaio, C.; Ferreira, J.J.; Simões, F.; Rosas, M.J.; Magalhães, M.; Correia, A.P.; Bastos-Lima, A.; Martins, R.; Castro-Caldas, A.. "DYSBOT: A single-blind, randomized parallel study to determine whether any differences can be detected in the efficacy and tolerability of two formulations of botulinum toxin type A - Dysport and Botox - Assuming a ratio of 4:1". Movement Disorders 12 6 (1997): 1013-1018. http://www.scopus.com/inward/record.url?eid=2-s2.0-0030725728&partnerID=MN8TOARS.
    10.1002/mds.870120627
  141. Vasconcelos, M.I.; Lima, V.P.; Iversson, L.B.; Rosa, M.D.; da Rosa, A.P.; da Rosa, E.S.; Pereira, L.E.; et al. "Hantavirus pulmonary syndrome in the rural area of Juquitiba, São Paulo metropolitan area, Brazil.". Revista do Instituto de Medicina Tropical de São Paulo 39 4 (1997): 237-238. http://www.scopus.com/inward/record.url?eid=2-s2.0-0031174040&partnerID=MN8TOARS.
  142. Sampaio, C.; Ferreira, J.J.; Pinto, A.A.; Crespo, M.; Ferro, J.M.; Castro-Caldas, A.. "Botulinum toxin type A for the treatment of arm and hand spasticity in stroke patients". Clinical Rehabilitation 11 1 (1997): 3-7. http://www.scopus.com/inward/record.url?eid=2-s2.0-0031050845&partnerID=MN8TOARS.
Capítulo de livro
  1. Anna Pompili; Alberto Abad; Paolo Romano; Isabel P. Martins; Rita Cardoso; Helena Santos; Joana Carvalho; Isabel Guimarães; Joaquim J. Ferreira. "Automatic Detection of Parkinson’s Disease: An Experimental Analysis of Common Speech Production Tasks Used for Diagnosis". 411-419. Springer International Publishing, 2017.
    10.1007/978-3-319-64206-2_46
Tese / Dissertação
  1. Lourenço, Nádia Filipa Cruz. "Curricular internsphip in a clinical pharmacology unit". Mestrado, 2016. http://hdl.handle.net/10773/16566.
  2. Carreiro, Rita Margarida Tavares. "Training in clinical studies coordination in a research centre: Estágio em coordenação de estudos clínicos num centro de investigação". Mestrado, 2011. http://hdl.handle.net/10773/5653.
Atividades

Orientação

Título / Tema
Papel desempenhado 		Curso (Tipo)
Instituição / Organização
2015 - 2017 Nocebo effect in Parkinson’s disease : a systematic review and meta-analysis
Orientador de Miguel Leal Rato
Universidade de Lisboa Faculdade de Medicina, Portugal
2015 - 2016 Estágio curricular num centro de investigação clínica
Orientador de Eunice Ferreira Vicente
Universidade de Lisboa Faculdade de Medicina, Portugal
2015 - 2016 Curricular internship in a clinical research unit.
Orientador de Nuno Miguel Dias Almeida
Universidade de Lisboa Faculdade de Medicina, Portugal
2015 - 2016 Curricular internship in clinical research
Orientador de João Pedro da Silva Almeida
Universidade de Lisboa Faculdade de Medicina, Portugal
2015 - 2016 Curricular internsphip in a clinical pharmacology unit
Orientador de Nádia Filipa Cruz Lourenço
Universidade de Lisboa Faculdade de Medicina, Portugal
2015 - 2016 Relatório de estágio curricular numa unidade de investigação clínica
Orientador
Universidade de Lisboa Faculdade de Medicina, Portugal
2014 - 2015 Curricular internship in a clinical pharmacology unit
Orientador
Universidade de Lisboa Faculdade de Medicina, Portugal
2014 - 2015 Curricular training report: clinical trials coordination in neurology
Orientador de Adriana Filipa da Silva Ferreira
Universidade de Lisboa Faculdade de Medicina, Portugal
2014 - 2015 Curricular training as study coordinator in a clinical research centre
Orientador de Andreia Assunção Sousa da Rocha
Universidade de Lisboa Faculdade de Medicina, Portugal
2013 - 2014 Estágio em coordenação de ensaios clínicos
Orientador de André Filipe da Silva Lopes Cardoso
Universidade de Lisboa Faculdade de Medicina, Portugal
2013 - 2014 Estágio em coordenação de ensaios clínicos
Orientador de Márcio Correia Barra
Universidade de Lisboa Faculdade de Medicina, Portugal
2013 - 2014 Curricular training in coordination of clinical trials in a clinical research unit
Orientador de Ana Cláudia Marques Salgueiro
Universidade de Lisboa Faculdade de Medicina, Portugal
2011 - 2012 Report on training in a clinical research centre
Orientador de Ana Teresa Martins Sousa Santos
Universidade de Lisboa Faculdade de Medicina, Portugal
2010 - 2011 Training in clinical studies coordination in a research centre
Orientador de Rita Margarida Tavares Carreiro
Universidade de Lisboa Faculdade de Medicina, Portugal

Organização de evento

Nome do evento
Tipo de evento (Tipo de participação) 		Instituição / Organização
2017/10/30 - 2017/10/30 Presidente da Comissão organizadora local do EAN Congress Lisbon 2017. (2017/10/30 - 2017/10/30)
Congresso (Presidente da Comissão Organizadora)
 European Academy of Neurology, Áustria
2017/06/26 - 2017/10/30 Co-organizador do curso Speech theraphy in Parkinson´s disease and Parkinsonism, Autumn School. (2017/10/28 - 2017/10/30)
Outro (Coorganizador)
 Campus Neurológico Sénior, Portugal
2017/09/01 - 2017/10/01 Director do 1st MDS-ES Summer School for Nurses. (2017/09/29 - 2017/10/01)
Outro (Outra)
 Campus Neurológico Sénior, Portugal
2017/03/17 - 2017/03/18 Co-organizador do Congresso SPDMov, Esposende. (2017/03/17 - 2017/03/18)
Congresso (Coorganizador)
 Sociedade portuguesa das doenças do movimento (SPDMov), Portugal

Participação em evento

Descrição da atividade
Tipo de evento 		Nome do evento
Instituição / Organização
2009 - 2009 Moderador no 12.º Workshop “Educação pela Ciência” do Gabinete de Apoio à Investigação Científica (GAPIC).
Universidade de Lisboa Faculdade de Medicina, Portugal

Arbitragem científica em revista

Nome da revista (ISSN) Editora
2017 - Atual Arquivos de Neuro-Psiquiatria (0004-282X) SciELO
2017 - Atual Basal Ganglia (2210-5336) Elsevier
2010 - Atual Parkinsonism & Related Disorders (1353-8020) Elsevier
2008 - Atual Journal of Neurology Neurosurgery & Psychiatry (1468-330X) BMJ
2008 - Atual Journal of Medical Ethics (1473-4257) BMJ
2008 - Atual Journal of Neural Transmission (1435-1463) Springer-Verlag
2007 - Atual Journal of Pain (1526-5900) Elsevier
2007 - Atual Journal of Neurology (1432-1459) Springer-Verlag
2007 - Atual Neuroscience Letters (0304-3940) Elsevier
2007 - Atual Sinapse
2006 - Atual Expert Review of Neurotherapeutics (1744-8360) Informa UK (Taylor & Francis)
2006 - Atual Expert Opinion on Drug Safety (1744-764X) Informa UK (Taylor & Francis)
2006 - Atual Aging Health (1745-5103) Future Medicine
2001 - Atual Journal of Movement Disorders (2093-4939) The Korean Movement Disorder Society
2000 - Atual CNS Drugs (1179-1934) Springer-Verlag
2000 - Atual European Journal of Neurology (1468-1331) Wiley (Blackwell Publishing)
2009 - 2009 The European Neurological Journal
2009 - 2009 Dovepress
2009 - 2009 Expert Opinion on Drug Metabolism & Toxicology (1744-7607) Informa UK (Taylor & Francis)
2005 - 2007 Acta Reumatológica Portuguesa

Comissão de avaliação

Descrição da atividade
Tipo de assessoria 		Instituição / Organização Entidade financiadora
2016 - 2017 Avaliador do painel de Medicina Clínica e Ciências da Saúde, Concurso para atribuição de Bolsas de Doutoramento e Pós Doutoramento Fundação para a Ciência e Tecnologia.
Avaliador
 Fundação para a Ciência e a Tecnologia, Portugal
2016/11/23 - 2016/11/23 Avaliador de trabalhos submetidos no III dia da Pedagogia e Educação Médica, Faculdade de Medicina da Universidade de Lisboa Universidade de Lisboa Faculdade de Medicina, Portugal
2016 - 2016 Membro do júri do concurso ao 19º Programa ”Educação pela Ciência”, Bolsas Centro Hospital Lisboa Norte/Faculdade de Medicina de Lisboa. Universidade de Lisboa Faculdade de Medicina, Portugal
2015/11/06 - 2015/11/08 Membro do Júri de avaliação de trabalhos apresentados nas II Jornadas do Internato Médico, Lisboa, Centro Hospitalar Lisboa Norte Centro Hospitalar Universitário Lisboa Norte EPE, Portugal
2015 - 2015 Membro do júri do prémio David Marsden
2012 - 2012 Revisor do review board for the 2012 NEURON joint transnational call “Novel Methods and Approaches towards the Understanding of Brain Diseases”.

Curso / Disciplina lecionado

Disciplina Curso (Tipo) Instituição / Organização
2017/05/10 - 2017/05/10 Organizador do IV Curso de Boas Práticas Clínicas, Faculdade de Medicina, Universidade de Lisboa, 10 de Maio, 2017. Boas Práticas Clínicas Universidade de Lisboa Faculdade de Medicina, Portugal
2016/07/15 - 2016/07/17 Director do MDS-ES Summer School for Young Neurologists, Lisbon, Portugal, July 15-17, 2016. MDS-ES Summer School for Young Neurologists Movement Disorders Society , Estados Unidos

Membro de associação

Nome da associação Tipo de participação
2008 - Atual Membro do Colégio da Especialidade de Farmacologia Clínica da Ordem dos Médicos
2001 - Atual Membro do Colégio da Especialidade de Neurologia da Ordem dos Médicos
1999 - Atual Membro da Movement Disorders Society
1996 - Atual Membro da Cochrane Collaboration
1995 - Atual Membro da Sociedade Portuguesa de Neurologia
1993 - Atual Membro da Secção das Doenças do Movimento da SPN
1992 - Atual Membro da Ordem dos Médicos
2015 - 2017 Membro da Task Force on Technology da Movement Disorders Society

Membro de comissão

Descrição da atividade
Tipo de participação 		Instituição / Organização
2008 - Atual Membro do Comité Científico da Associação Portuguesa de Doentes de Parkinson.
Membro
 Associação Portuguesa de Doentes de Parkinson, Portugal
1998/04 - 1999 Membro da Comissão para a Melhoria da Informação Médica.
Membro
 Centro Hospitalar Universitário Lisboa Norte EPE, Portugal

Outro júri / avaliação

Descrição da atividade Instituição / Organização
2009 - Atual Revisor de candidaturas de alunos de medicina submetidos aos Programas “Educação pela Ciência” do Gabinete de Apoio à Investigação Científica (GAPIC). Universidade de Lisboa Faculdade de Medicina, Portugal
2007 - 2009 Revisor de projectos submetidos para financiamento: Parkinson’s Disease Society, UK (2007, 2009).
2007 - 2007 Revisor de projectos submetidos para financiamento: Secção de Doenças do Movimento da SPN. Sociedade Portuguesa de Neurologia, Portugal
2007 - 2007 Revisor de projectos submetidos para financiamento: Action Medical Research, UK.
Distinções

Prémio

2017 Prémio Científico Universidade de Lisboa/Caixa Geral de Depósitos nas áreas da Saúde
Caixa Geral de Depositos, Portugal
2017 Prémio “Young Investigator Poster Award” na reunião “200 Year Celebration of James Parkinson”, Royal Academy, com o poster “neuromelanin Magnetic Resonance Imaging of the Substantia Nigra in LRRK2 – related Parkinson´s disease
Royal Academy, Butão

Título

2017 “Membre d´Excellence”
Société Française de Neurologie, França

Outra distinção

1998 Prémio Arsénio Cordeiro
Hospital de Santa Maria, Portugal
1992 Bolsa Glaxo para finalistas de Medicina do ano 1991/92
1990 Prémio Sandoz de Neurologia